Research conducted on CT26 models has demonstrated that regulatory T cells (Tregs) with high levels of TIM3+ accumulate in the tumor microenvironment prior to the exhaustion of CD8+ and CD4+ T cells. The gene discussed is CD4; the disease is neoplasm.